Literature DB >> 18095057

Bone quality: the material and structural basis of bone strength.

Ego Seeman1.   

Abstract

The material composition and structural design of bone determine its strength. Structure determines loads that can be tolerated but loads also determine structure. Bone modifies its material composition and structure to accommodate loads by adaptive modeling and remodeling. Adaptation is successful during growth but not aging because accumulating insults, including a reduction in the volume of bone formed in the basic multicellular unit (BMU), increased resorption in the BMU, increased remodeling rate in midlife in women and in some men because of sex hormone deficiency, and in both sexes in old age as a consequence of secondary hyperparathyroidism and reduced periosteal bone formation, all of which compromises the material composition of bone and its structure. An understanding of the mechanisms of adaptation and failed adaptation provides rational approaches to interventions that can prevent or restore bone fragility.

Entities:  

Mesh:

Year:  2008        PMID: 18095057     DOI: 10.1007/s00774-007-0793-5

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  34 in total

1.  Mechanical consequences of bone loss in cancellous bone.

Authors:  J C van der Linden; J Homminga; J A Verhaar; H Weinans
Journal:  J Bone Miner Res       Date:  2001-03       Impact factor: 6.741

Review 2.  Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.

Authors:  S C Manolagas
Journal:  Endocr Rev       Date:  2000-04       Impact factor: 19.871

3.  Peak trabecular vertebral density: a comparison of adolescent and adult females.

Authors:  V Gilsanz; D T Gibbens; M Carlson; M I Boechat; C E Cann; E E Schulz
Journal:  Calcif Tissue Int       Date:  1988-10       Impact factor: 4.333

4.  Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age.

Authors:  Xiao-Fang Wang; Yunbo Duan; Thomas J Beck; Ego Seeman
Journal:  Bone       Date:  2005-06       Impact factor: 4.398

5.  Structural and biomechanical basis of racial and sex differences in vertebral fragility in Chinese and Caucasians.

Authors:  Yunbo Duan; Xiao-Fang Wang; Alison Evans; Ego Seeman
Journal:  Bone       Date:  2005-06       Impact factor: 4.398

6.  Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss.

Authors:  Y Duan; C H Turner; B T Kim; E Seeman
Journal:  J Bone Miner Res       Date:  2001-12       Impact factor: 6.741

7.  Age- and sex-related changes in iliac cortical bone mass and remodeling.

Authors:  H Brockstedt; M Kassem; E F Eriksen; L Mosekilde; F Melsen
Journal:  Bone       Date:  1993 Jul-Aug       Impact factor: 4.398

8.  Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength.

Authors:  Kenneth M Kozloff; Angela Carden; Clemens Bergwitz; Antonella Forlino; Thomas E Uveges; Michael D Morris; Joan C Marini; Steven A Goldstein
Journal:  J Bone Miner Res       Date:  2004-01-12       Impact factor: 6.741

9.  Bone loss and bone size after menopause.

Authors:  Henrik G Ahlborg; Olof Johnell; Charles H Turner; Gunnar Rannevik; Magnus K Karlsson
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

View more
  78 in total

1.  A poisson process model for hip fracture risk.

Authors:  Zvi Schechner; Gangming Luo; Jonathan J Kaufman; Robert S Siffert
Journal:  Med Biol Eng Comput       Date:  2010-06-04       Impact factor: 2.602

2.  Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study.

Authors:  B M Misof; P Roschger; S Blouin; R Recker; K Klaushofer
Journal:  Osteoporos Int       Date:  2015-12-09       Impact factor: 4.507

3.  Inhibition of CaMKK2 reverses age-associated decline in bone mass.

Authors:  Zachary J Pritchard; Rachel L Cary; Chang Yang; Deborah V Novack; Michael J Voor; Uma Sankar
Journal:  Bone       Date:  2015-02-25       Impact factor: 4.398

Review 4.  Skeletal Implications of Chronic Obstructive Pulmonary Disease.

Authors:  Barbara M Misof; Carolina A Moreira; Klaus Klaushofer; Paul Roschger
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

Review 5.  Quantitative ultrasound in the assessment of skeletal status.

Authors:  Giuseppe Guglielmi; Judith Adams; Thomas M Link
Journal:  Eur Radiol       Date:  2009-03-04       Impact factor: 5.315

6.  Bone ultrastructure: evolution during osteoporosis and aging.

Authors:  C Laurent Benhamou
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

Review 7.  Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer.

Authors:  Francesco Bertoldo; Giuseppe Tonini; Bruno Vincenzi; Daniele Santini
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

8.  Osteocyte-Intrinsic TGF-β Signaling Regulates Bone Quality through Perilacunar/Canalicular Remodeling.

Authors:  Neha S Dole; Courtney M Mazur; Claire Acevedo; Justin P Lopez; David A Monteiro; Tristan W Fowler; Bernd Gludovatz; Flynn Walsh; Jenna N Regan; Sara Messina; Daniel S Evans; Thomas F Lang; Bin Zhang; Robert O Ritchie; Khalid S Mohammad; Tamara Alliston
Journal:  Cell Rep       Date:  2017-11-28       Impact factor: 9.423

9.  Role of Sost in Wnt signal pathway in osteoporosis rats and regulating effect of soybean isoflavones on Wnt signal pathway.

Authors:  Hai Dong Liang; Fang Yu; Ping Lv; Zheng Nan Zhao; Zhi Hong Tong
Journal:  Mol Biol Rep       Date:  2014-04-24       Impact factor: 2.316

Review 10.  The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.

Authors:  Martin Jannot; Fabrice Mac-Way; Vanessa Lapierre; Marie-Helene Lafage-Proust
Journal:  J Nephrol       Date:  2017-09-12       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.